doi: 10.7326/0003-4819-137-8-200210150-00014.
New federal initiatives to enhance the medical treatment of opioid dependence
Affiliations
- PMID: 12379070
- DOI: 10.7326/0003-4819-137-8-200210150-00014
Item in Clipboard
New federal initiatives to enhance the medical treatment of opioid dependence
Ann Intern Med.
.
Abstract
Opioid dependence is a chronic relapsing medical condition with substantial health and societal complications. Recent federal initiatives are designed to enhance the medical treatment of patients with opioid dependence and will expand the role of internists in the care of these patients. These initiatives include a process for federal exemptions to allow for pharmacologic treatment in office settings, waivers for the use of new medications, and new rules governing the oversight and distribution of opioid agonist medications for maintenance treatment. This perspective describes these initiatives and their implications for internists.
Similar articles
-
Federal plan for prescriber education on opioids misses opportunities.Ann Intern Med. 2012 Aug 7;157(3):205-6. doi: 10.7326/0003-4819-157-3-201208070-00448. Ann Intern Med. 2012. PMID: 22868838 No abstract available.
-
Public policy statement on Office-Based Opioid Agonist Treatment (OBOT).J Addict Dis. 2005;24(3):153-61. doi: 10.1300/J069v24n03_12. J Addict Dis. 2005. PMID: 16186090 No abstract available.
-
Healthcare Reform. Opioid Crisis.Issue Brief Health Policy Track Serv. 2018 Dec 24;2018:1-89. Issue Brief Health Policy Track Serv. 2018. PMID: 30681792 No abstract available.
-
The US Opioid Crisis: Current Federal and State Legal Issues.Anesth Analg. 2017 Nov;125(5):1675-1681. doi: 10.1213/ANE.0000000000002403. Anesth Analg. 2017. PMID: 29049113 Review.
-
Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?CNS Drugs. 2008;22(2):99-111. doi: 10.2165/00023210-200822020-00002. CNS Drugs. 2008. PMID: 18193922 Review.
Cited by
-
Building medication for opioid use disorder prescriber capacity during the opioid epidemic: Prescriber recruitment trends and methods.J Subst Use Addict Treat. 2023 Apr;147:208975. doi: 10.1016/j.josat.2023.208975. Epub 2023 Feb 10. J Subst Use Addict Treat. 2023. PMID: 36804353 Free PMC article.
-
Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.PLoS One. 2017 Dec 1;12(12):e0184876. doi: 10.1371/journal.pone.0184876. eCollection 2017. PLoS One. 2017. PMID: 29194445 Free PMC article.
-
Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods.Contemp Clin Trials. 2017 Sep;60:105-112. doi: 10.1016/j.cct.2017.07.006. Epub 2017 Jul 8. Contemp Clin Trials. 2017. PMID: 28689852 Free PMC article.
-
Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.J Behav Health Serv Res. 2017 Jul;44(3):351-363. doi: 10.1007/s11414-017-9553-z. J Behav Health Serv Res. 2017. PMID: 28488155
-
Infectious Disease (ID) Learning Unit: What the ID Clinician Needs to Know About Buprenorphine Treatment for Opioid Use Disorder.Open Forum Infect Dis. 2016 Dec 27;4(1):ofw251. doi: 10.1093/ofid/ofw251. eCollection 2017 Winter. Open Forum Infect Dis. 2016. PMID: 28480247 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
